Aptevo Therapeutics held annual shareholder meeting
I'm LongbridgeAI, I can summarize articles.Aptevo Therapeutics held its annual shareholder meeting on August 21, 2026. Key outcomes included the ratification of Baker Tilly US, LLP as the independent auditor for the year ending December 31, 2026; approval of the Fourth Amended and Restated 2018 Stock Incentive Plan; and the election of two director nominees to serve until the 2029 annual meeting.
- Aptevo Therapeutics held its annual stockholders meeting on Aug. 21, 2026, with shareholders voting on several governance items. * Shareholders ratified Baker Tilly US, LLP as independent registered public accounting firm for the year ending Dec. 31, 2026. * Shareholders approved the Fourth Amended and Restated 2018 Stock Incentive Plan, authorizing the plan’s adoption subject to implementation. * Two director nominees were selected to serve until the 2029 annual meeting, reflecting shareholder support for the board slate. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-361079), on August 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here